Summary
Updated Aug 31, 2026
Susan L. N. Vogt is Director of Anika Therapeutics, Inc. (ANIK). 1 SEC Form 4 filing on record, dated 20 June 2025.
Recent Transactions
1Every recent SEC Form 4 transaction Susan L. N. Vogt has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Susan L. N. Vogt go back to 2025: 1 primary Form 4 filing, an average of 0.5 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Susan L. N. Vogt files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- John B. Henneman III - $73K of ANIK open-market activity in the last 12 months
- Gary P. Fischetti - $41K of ANIK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Susan L. N. Vogt?
Susan L. N. Vogt is a corporate insider, tracked as Director of Anika Therapeutics, Inc. (ANIK). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Susan L. N. Vogt last file a Form 4?
The only primary Form 4 on record is dated 20 June 2025.
Where can I see all of Susan L. N. Vogt's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Susan L. N. Vogt and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial